Xenetic Biosciences Financial Overview
Xenetic Biosciences's market cap is currently $6.49M. The company's EPS TTM is $-0.33; its P/E ratio is -1.43; Xenetic Biosciences is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
